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Abstract
Background: MicroRNA (miRNA) are small non-coding RNA molecules critical for regulating cellular function, and
are abundant in the maturing oocyte and developing embryo. MiRNA-21 (MIR21) has been shown to elicit
posttranscriptional gene regulation in several tissues associated with rapid cell proliferation in addition to
demonstrating anti-apoptotic features through interactions with PDCD4 mRNA and other targets. In many
tissues, MIR21 interacts and suppresses PDCD4 due to the strong complementation between MIR21 and the
PDCD4 3′UTR.
Methods: The objective of this project was to examine the relationship between MIR21 and PDCD4
expression in porcine oocytes during in vitro maturation and assess the impact of MIR21 inhibition during
oocyte maturation on early embryo development. Additionally, we evaluated the effect of gonadotropins in
maturation media and the presence of cumulus cells to determine their ability to contribute to MIR21 abundance in
the oocyte during maturation.
Results: During in vitro maturation, expression of MIR21 increased approximately 6-fold in the oocyte and 25-fold in
the cumulus cell. Temporally associated with this was the reduction of PDCD4 protein abundance in MII arrested
oocytes compared with GV stage oocytes, although PDCD4 mRNA was not significantly different during this transition.
Neither the presence of cumulus cells nor gonadotropins during in vitro maturation affected MIR21 abundance in
those oocytes achieving MII arrest. However, inhibition of MIR21 activity during in vitro maturation using antisense
MIR21 suppressed embryo development to the 4–8 cell stage following parthenogenetic activation.
Conclusions: MIR21 is differentially expressed in the oocyte during meiotic maturation in the pig and inhibition of
MIR21 during this process alters PDCD4 protein abundance suggesting posttranscriptional regulatory events involving
MIR21 during oocyte maturation may impact subsequent embryonic development in the pig.
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Background
Germinal vesicle breakdown (GVBD) is the first physical
sign that an oocyte is committed to maturation and also
represents the onset of a period of transcriptional quies-
cence which persists until the activation of the embryonic
genome. During this period, changes in mRNA and protein
abundance within the oocyte can occur through interac-
tions with the surrounding cumulus cells and/or through
posttranscriptional gene regulation (PTGR) within the
oocyte. MicroRNA (miRNA) represent a unique RNA class
that function as potent regulators of transcription and
protein abundance through PTGR [12]. MiRNA are small
(18–24 nt), non-coding RNA molecules that confer PTGR
through several mechanisms, such as impairing translation
efficiency and affecting mRNA stability following inter-
action with the 3′ untranslated region (3′UTR) of target
mRNA molecules [5, 6]. Numerous miRNA are expressed
in the mouse oocyte and developing embryo and it has
been demonstrated that the conditional knockout of
DICER, an enzyme involved in miRNA processing, during
oocyte development impairs the production of oocytes
capable of being fertilized and developing normally [38].
Estimations predict approximately 1,000 miRNA are
present in the human genome having the potential ability
to impact approximately 30 % of protein coding genes [28].
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Some miRNA have numerous mRNA targets [27] while
others have few predicted targets [8, 34].
Utilizing miRNA microarray analysis and deep sequen-
cing we have previously identified microRNA-21 (MIR21)
as an up-regulated miRNA during porcine oocyte in vitro
maturation [41]. In mice it has been reported that
luteinizing hormone may increase the expression of MIR21
in mouse granulosa cells and in vivo MIR21 inhibition has
a negative impact on ovulation rate [11]. MIR21 is a
well characterized miRNA that has demonstrated the
ability to confer PTGR oncogenic cell lines by affect-
ing cellular proliferation through controlling apoptosis
[9, 13, 15, 42]. The MIR21 gene is transcribed via
RNA polymerase II and is located in intronic regions
of the transmembrane 49 gene (TMEM49; also re-
ferred to as VMP1) [10, 17]. The mature MIR21 se-
quence was first identified in human HeLa cells [22]
and has since been predicted and verified to be
present in the transcriptome of several other species
including the pig. The anti-apoptotic capabilities of
MIR21 in cancer cells are manifested through the
ability to suppress critical apoptotic genes including
programmed cell death 4 (PDCD4, previously referred to
as neoplastic transformation inhibitor) [3, 16, 24, 33].
MIR21 interacts with PDCD4 through binding with
complementary sequence in the 3′UTR of PDCD4
mRNA resulting in reduced translation and subse-
quently reduced protein abundance in oncogenic cell
lines [3, 24]. Importantly the 3′UTR of pig PDCD4
possesses a conserved MIR21 recognition sequence,
particularly in the seed sequence. This suggests that if
both MIR21 and PDCD4 are present in the oocyte,
MIR21 could impact PDCD4 protein abundance as
the necessary accessory proteins for miRNA function
are present in the oocyte during GVBD and progres-
sion to MII arrest.
Our working hypothesis that increased MIR21 abun-
dance in the maturing cumulus oocyte complex of the
pig is associated with posttranscriptional regulation of
PDCD4 expression in the oocyte and that suppression
of MIR21 function during oocyte maturation will com-
promise subsequent embryonic development. The
objective of this study was to determine expression pat-
terns of MIR21 and demonstrate its potential interac-
tions with PDCD4 in the cumulus oocyte complex
(COC) during oocyte maturation in the pig. Here we
demonstrate PDCD4 protein down regulation is tem-
porally associated with MIR21 abundance increase dur-
ing in vitro oocyte maturation. These data indicate a
reduced ability of MIR21 to suppress PDCD4 protein
abundance in the presence of a MIR21 inhibitor sug-
gesting a biological interaction between MIR21 and
PDCD4 mRNA occurs during in vitro oocyte matur-
ation in the pig.
Methods
Animal use was in accordance with the Guiding Principles
for Care and Animals and procedures were approved
by the Iowa State Institutional Animal Care and Use
Committee.
In vitro maturation
All chemicals were purchased from Sigma Chemical Co.
(St. Louis MO) unless otherwise stated. Sow ovaries were
obtained from a local abattoir for isolation of cumulus
oocyte complexes (COCs) to be subjected to in vitro mat-
uration (IVM) as previously described [41, 44]. Briefly, fol-
licles (3–5 mm) were aspirated and COC were collected
and washed in TL-Hepes with 0.1 % polyvinyl alcohol
(PVA). Cumulus oocyte complexes were cultured in mat-
uration media (Tissue Culture Media 199 (TCM-199))
containing 0.57 mM L-cysteine, follicle stimulating hor-
mone (0.5 μg/mL), luteinizing hormone (0.5 μg/mL),
and epidermal growth factor (10 ng/mL) for 42–44 h at
39.0 °C in 5 % CO2. Prior to in vitro maturation, an ali-
quot of GV stage oocytes for each replication were ran-
domly selected from the COC pool. GV stage oocytes
used for analysis were stripped of cumulus cells via vor-
tex (6 to 8 min) in 1 % hyaluronidase in TL-Hepes-
PVA. Following in vitro maturation oocytes were
stripped of cumulus cells by vortexing 4–6 min in TL-
Hepes-PVA supplemented with 1 % hyaluronidase, and
Metaphase II arrested (MII) oocytes were identified by
the presence of an extruded polar body. Cumulus cells
before and after maturation and GV and MII oocytes
(25 oocytes per pool) were snap frozen in liquid nitro-
gen and stored at −80 °C until used for quantitative
reverse transcription PCR (RT-qPCR). Pools of GV and
MII arrested oocytes from the same replications (50
oocytes per pool) were utilized for Western blot
analysis.
MIR21 expression in oocytes with and without LH and
FSH during in vitro maturation
To determine the effect of LH and FSH on MIR21 ex-
pression in oocytes during in vitro maturation COCs
were matured in defined maturation media with LH and
FSH as described above or containing only LH, only
FSH, or lacking both. COCs were washed four times and
cultured in the designated hormone treatment in groups
of 80–90 COCs per well. COCs were cultured for 42 h,
denuded of cumulus cells by vortexing as described
above and MII oocytes were identified by the presence
of a polar body. This experiment consisted of four bio-
logical replications. Maturation rates, as defined by the
percentage of oocytes achieving MII arrest, were
recorded and MII oocytes from each treatment and rep-
lication were collected in pools and used for MIR21
expression analysis as described above.
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MIR21 expression in oocytes cultured with and without
cumulus cells
To determine the effect of cumulus cell presence on
MIR21 expression in oocytes during in vitro maturation
we subjected COCs to one of three treatments: 1) stand-
ard in vitro maturation as described above using intact
COCs, 2) in vitro maturation following cumulus cell
removal and then utilization of detached cumulus cells
for culture with denuded oocytes or, 3) denuded oocytes
matured without the presence of cumulus cells. Cumulus
cells were removed by gentle vortex in 1 % hyaluronidase
in TL-Hepes, washed twice in 200 μL of maturation media
and then resuspended in 200 μL of maturation media and
added to the in vitro maturation culture plates which con-
tained 300 μL maturation media and the denuded oocytes.
Final volume of culture media for all plates was 500 μL
and each well contained 75–85 oocytes. This experiment
consisted of four biological replications. Maturation rates,
as defined by the percentage of oocytes achieving MII
arrest, were recorded and MII oocytes from each treat-
ment and replication were collected in pools and used for
MIR21 expression analysis as described above.
MIR21 inhibition during in vitro maturation
Peptide nucleic acids (PNA) are artificially constructed
oligonucleotides with strong affinity and specificity to
endogenous nucleotides while resistant to nucleases
making them ideal for miRNA inhibition [31]. We used
an anti-MIR21 PNA (Panagene Inc. Daejeon, Korea)
designed to specifically bind to and prevent MIR21
activity. A scrambled PNA with no predicted targets was
used as a negative control (Panagene Inc., Daejeon,
Korea). PNA oligonucleotides were diluted in matur-
ation media at a stock concentration of 100 nM/μL and
then added to maturation media on the day of COC col-
lection to acquire a final concentration of 2.0 nM and
0.2 nM. A control group without PNA was used to
evaluate the potential toxicity of the PNA.
Parthenogenetic activation of MII oocytes, used to
remove the confounding effects of miRNA introduced
by sperm, was performed with 50 oocytes from each
treatment to determine developmental competence of
embryos up to 60 h. MII oocytes were washed in a high
calcium activation media (Mannitol 0.28 M, CaCl2
1.0 mM, MgCl2 0.1 mM, HEPES 0.5 mM and BSA
1 mg/mL), then placed between two electrodes covered
with activation media and activated by two consecutive
30 μsec pulses at 1.2 kV/cm. Following activation,
zygotes were washed and cultured in porcine zygote
medium-3 (PZM3) at 39 °C in 5 % CO2 [21]. At 60 h
embryos were evaluated for development and the num-
ber of embryos with four or more uniform blastomeres
was recorded.
Quantitative RT-PCR of oocytes and cumulus cells
Oocytes were collected and denuded of cumulus cells as
described above. Oocytes from each stage of develop-
ment and treatment were collected in pools of exactly
25 oocytes in 5 μL of PBS. As before using a precise
number of oocytes per reaction we were able to avoid
the introduction of additional variation associated with
reference genes [41]. Both PDCD4 and MIR21 ana-
lysis were analyzed from the same oocyte sample
lysis. TaqMan™ Gene Expression Cells-to-Ct™ Kit (Ap-
plied Biosystems, Carlsbad, CA) was used to lyse
oocytes and prepare samples for RT-qPCR. Lysis solu-
tion and DNase from the Cells-to-Ct kit were added
to each oocyte pool at 4.95 and 0.05 μL, respectively,
and incubated at RT for 5 min. Stop solution (0.5 μL)
was added, incubated for an additional 2 min and
placed on ice. Two μl of the sample lysis was added
to each RT-qPCR reaction. PDCD4 forward (5′-
ACAGTTGGTGGGCCAGTTTATTGC-3′) and re-
verse (5′-CTTTGCGCCTTCCACCTTTAGACA- 3′)
primers were used to determine mRNA abundance of
PDCD4 within each pool. QuantiTect® SYBR® Green
RT-PCR Kit (Qiagen) was used for the RT-qPCR reac-
tion for PDCD4 according to manufacturer’s recom-
mendations. The standard cycling conditions were
50 °C for 30 min, 95 °C for 15 min followed by 45 -
cycles of 95 °C for 15 s, 60 °C for 30 s, and 72 °C for
30 s followed by melting curve analysis.
MIR21 was quantified using TaqMan® MicroRNA
Reverse Transcription kit (Applied Biosystems Carlsbad,
CA) for the reverse transcription (RT) reaction and the
primers and probe used were TaqMan® MicroRNA Assay
for hsa-MIR21 (Applied Biosystems, Carlsbad, CA)
according to manufacturer’s recommendations. The RT
reaction was 20 μL consisting of 13 μL master mix, 3 μL
primers, and 4 μL sample lysis. Reverse transcription
conditions were 16 °C for 30 min, 42 °C for 30 min and
85 ° C for 5 min. The final volume for all RT-qPCR reac-
tions was 20 μL which include 1.33 μL of the RT prod-
uct, 1 μL TaqMan MicroRNA Assay (20x), 10 μL
TaqMan 2X Universal PCR Master Mix and 7.67 nucle-
ase free water. The thermal cycling conditions for the
TaqMan MicroRNA RT-qPCR were 95 °C for 10 min,
followed by 45 cycles of 95 °C for 15 s and 60 °C for
60 s. Fluorescent data acquisition was during the 60 °C
extension step.
For analysis of MIR21 expression in cumulus cells
total RNA was extracted from cumulus cells of GV stage
and MII arrested oocytes using the mirVana RNA isola-
tion kit (Life Technologies, Grand Island, NY), 10 ng of
total RNA was utilized for the RT reaction conducted
the same way as the oocyte samples. For cumulus cells,
cycle threshold values were normalized to expression of
another small RNA, RNU43, prior to comparison
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between stages and statistical analysis. All samples were
assayed in duplicate. The comparative CT method was
used to calculate relative fold changes between samples
as previously described [35].
PDCD4 Western blot analysis
Pools of 50 denuded GV and MII oocytes within a replica-
tion were collected, washed in PBS, and stored at −80 °C
until used for Western blot analysis. Oocyte pools were
lysed in 2.5 μL of 5X SDS (total sample volume 12.5 μL)
at 95 °C for 4 min followed by 1 min on ice and then cen-
trifugation at 1000 rpm for 1 min at RT. Samples were
then loaded into a 4–20 % Tris glycine gel (Lonza PAGEr®
Gold Precast Gels). The BioRad Mini PROTEAN Tetra
System was used to run the gel at 60 V for 30 min
followed by 120 V for 90 min. The gel was transferred to a
nitrocellulose membrane for 1 h at 100 V at 4 °C. In
addition to utilizing an exact number of oocytes per lane,
Ponceau S staining was used to confirm relative transfer
efficiency between lanes and equivalent total protein load-
ing per lane. Membrane blocking was conducted using
5 % milk in PBST (PBS with 0.5 % Tween 20) for 1 h at
RT. A rabbit anti-PDCD4 monoclonal antibody (Abcam,
ab79405) was added (1:1000 dilution) to the membrane
in 0.5 % milk in PBST overnight at 4 °C and a negative
control membrane lacking primary antibody was also con-
ducted. Following primary antibody incubation, the mem-
branes were washed with PBST three times at RT for
10 min each. Donkey anti-Rabbit IgG (Amersham™ ECL™
NA934) was incubated (1:2000) with the membrane for
1 h at RT. The membrane was then washed three times
for 10 min each at RT. Horseradish peroxidase substrate
(Millipore, Billerica, MA) was added to the membrane
for 1 min in the dark. The membrane was then exposed to
x-ray film and developed for visualization. Average pixel
intensity for the protein corresponding to 52 kDa (PDCD4
molecular weight) was conducted using Image J [1].
MIR21 in situ hybridization in the developing follicle
Ovaries were preserved in 4 % paraformaldehyde and
utilized for in situ hybridization to determine MIR21
expression. Ovary sections (5 μm) were then mounted
on slides for analysis. Each section was subjected to
CitriSolv (Fisher Scientific) twice for five minutes rehy-
drated in two changes each of 100 % ethanol for 3 min,
followed by 95 % ethanol for one minute and finally
80 % ethanol for one minute. Slides were immersed in
heated citrate buffer (95 °C) for 30 min and then cooled
to RT. Once at RT slides were blocked for 30 min with
5 % BSA. Slides were then placed in hybridization solu-
tion for 1 h at 65 °C. The 5′ fluorescein labeled miRCURY
LNA detection probe (Exiqon) was added and slides were
incubated in high humidity overnight at 65 °C. Slides were
then washed in saline-sodium citrate (SSC) solution and
PBST at RT. Anti-fade DAPI was added and a cover slip
was placed over each section. Primary and secondary folli-
cles were imaged at 400X and tertiary follicles were
imaged at 200X with a Leica microscope.
Statistical analysis
PROC MIXED of the Statistical Analysis System was
used to determine statistical differences of all data in-
cluding percentage maturation and differences in CT
value for RT-qPCR data. Significance (P < 0.05) was
determined for the model and least-square means was
used to determine significant differences between sam-
ples. The effect of oocyte stage on MIR21 and PDCD4
expression (CT value) was determined. Treatment effect
for the PNA inhibitor of MIR21, presence or absence of
gonadotropins, and the presence or absence of cumulus
cells during in vitro maturation on MIR21 expression
was evaluated. Replication was included as a covariate.
Graphs depicting percent change were adjusted to reflect
the GV stage as 100 % and all other treatments are rela-
tive to GV. Data are displayed as mean ± SEM.
Results
MIR21 expression is temporally regulated during porcine
cumulus oocyte complex maturation
To determine the relationship between MIR21 and its
putative target PDCD4, during in vitro maturation, RT-
qPCR and Western blot analysis were utilized to evalu-
ate expression of MIR21 and PDCD4 in GV and MII
stage oocytes and cumulus cells. During the transition
from GV to MII, MIR21 was up-regulated approximately
6-fold in oocytes (P = 0.001, Fig. 1a) and approximately
25-fold in cumulus cells (P = 0.003, Fig. 1b). In the same
samples PDCD4 mRNA abundance was not statistically
different (P = 0.34, Fig. 1a). Western blot analysis
demonstrated PDCD4 protein abundance was reduced
(P = 0.02) in oocytes during the transition from GV
stage to MII arrested oocytes (Fig. 1c and d).
Gonadotropins in maturation media influence maturation
rate but not MIR21 abundance in MII arrested oocytes
To determine the effect of gonadotropins on MIR21 ex-
pression during in vitro oocyte maturation, we matured
COCs with and without luteinizing hormone (LH) and
follicle stimulating hormone (FSH). Maturation rates
were not different between media containing only LH
(62.7 ± 1.4 %) compared with control maturation (61.7 ±
1.2 %, Fig. 2a). However, progression to MII arrest was
significantly decreased (P < 0.001) when COCs were
cultured in maturation media with only FSH (47.8 ±
2.5 %) or lacking both FSH and LH (47.4 ± 0.9, Fig. 2a).
MIR21 expression in MII arrested oocytes was not sig-
nificantly different between the control and treatment
groups (P = 0.68) (Fig. 2b).
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Cumulus cells influence oocyte maturation but not MIR21
abundance in MII arrested oocytes
To determine the impact of cumulus cell presence on
MIR21 abundance in the oocyte during in vitro matur-
ation we compared MIR21 expression in MII arrested oo-
cytes following maturation of intact COCs, denuded
oocytes cultured in the presence of cumulus cells and de-
nuded oocytes cultured without cumulus cells. Maturation
rate for control COCs was 58.4 ± 1.5 % which tended to
be greater than denuded oocytes cultured with cumulus
cells (51.2 ± 4.0 %, P = 0.07). However, denuded oocytes
cultured without cumulus cells had significantly lower
(42.5 ± 2.0 %) maturation rates than intact COCs (P <
0.05) and denuded oocytes cultured with cumulus cells (P
< 0.05, Fig. 3a). MIR21 expression in MII arrested oocytes
was not affected by the presence or absence of cumulus
cells during maturation (P = 0.82). GV oocytes had
lower MIR21 expression (P < 0.05) compared to MII
arrested oocytes for all treatments (Fig. 3b), consistent
with data from the experiment presented in Fig. 1.
Inhibition of MIR21 affects oocyte maturation and PDCD4
protein expression
Using a fluorescently labeled MIR21 antagonist we first
demonstrated its ability to translocate into both the
cumulus cell and the oocytes (data not shown). All oo-
cytes exposed to the fluorescently labelled inhibitor
demonstrated a measurable level of fluorescence com-
pared with oocytes treated with a non-fluorescently
tagged control inhibitor, although some variability in the
intensity of the fluorescence existed between oocytes.
Anti-MIR21 antisense oligonucleotides were added to
maturation media during oocyte maturation to deter-
mine the effects of MIR21 inhibition on maturation rate
and PDCD4 expression in MII arrested oocytes. Inhib-
ition of MIR21 using an anti-MIR21 PNA during oocyte
maturation decreased (P < 0.01) the percentage of
oocytes achieving MII after 42 h of culture (Table 1).
Oocytes cultured in the presence of the negative control
inhibitor (NC-PNA 2.0 nM) had similar maturation rates
compared to control maturation conditions (P > 0.05)
and greater (P < 0.05) maturation rates compared to the
MIR21 inhibited oocytes (Table 1).
The effect of MIR21 inhibition on PDCD4 protein
abundance was analyzed by Western blot with pools of
50 oocytes within each treatment and presented as a
percentage of GV stage PDCD4 abundance. Western
blot analysis demonstrated significantly lower PDCD4
abundance in control MII arrested oocytes (31.9 % of
GV) compared to MII arrested oocytes matured in the
presence of 2.0 nM MIR21 antagonist (69.7 % of GV; P
< 0.05). PDCD4 abundance in MII oocytes subjected to
IVM in the presence of low (0.2 nM) MIR21 inhibitor
concentration was similar (26.4 % of GV stage) to
control MII oocytes and oocytes cultured with either
concentration of NC-PNA possessed a similar quantity
or less of PDCD4 compared to GV oocytes (Fig. 4).
MIR21 inhibition during in vitro maturation impacts
parthenogenetic embryo development
Metaphase II arrested oocytes were parthenogenetically
activated (to eliminate confounding impact of sperm-
Fig. 1 MIR21 expression is significantly increased in cumulus cells
and oocytes during in vitro maturation. a RT-qPCR analysis for MIR21
and PDCD4 mRNA in GV stage and MII arrested oocytes (n = 4). b
RT-qPCR analysis for MIR21 in cumulus cells isolated from GV stage
and in vitro matured oocytes (n = 4). c PDCD4 Western blot analysis of
GV stage and MII arrested oocytes. Pixel intensity was quantified with
ImageJ and demonstrates a decrease in PDCD4 protein abundance
in MII oocytes compared with GV oocytes (n = 3). d Representative
Western blot of PDCD4 protein detection in oocytes representing the
52 KDa band. a,bMeans ± SEM with different superscripts are
different (P < 0.05)
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borne miRNA) following in vitro maturation to test the
hypothesis that MIR21 inhibition during in vitro oocyte
maturation negatively impacts early embryo develop-
ment prior to activation of the embryonic genome at the
4-cell stage of development. The number of embryos
achieving the 4-cell stage of development or greater
within 60 h post activation was significantly (P < 0.05)
affected by MIR21 inhibition during in vitro maturation
(Table 1). Development to the 4-cell stage or greater
within 60 h post activation was greatest for control
oocytes (73.0 ± 5.7) compared with oocytes matured in
the presence of a MIR21 inhibitor (41.7 ± 12.1) or in the
presence of a negative control PNA (60.2 ± 15.8).
MIR21 abundance in the developing pig follicle
In situ hybridization of MIR21 demonstrated expression
throughout the granulosa cells and the oocyte (Fig. 5). In
primary follicles expression is present in the oocyte with
faint expression in the surrounding cells. However sec-
ondary and tertiary follicles express MIR21 more abun-
dantly in the oocyte as well as the surrounding cumulus
cells compared to primary follicles. Based on staining
intensity, MIR21 abundance appears greatest in oocytes
and granulosa cells of tertiary follicles.
Discussion
While abundant in the developing oocyte and mouse
ovary [11, 14] miRNA expression and function during
pig oocyte maturation and early embryo development is
only in the initial stages of characterization [18, 41]. The
potential ability of MIR21 to interact with PDCD4 lead-
ing to posttranscriptional gene regulation of PDCD4
protein expression in the maturing pig oocyte as demon-
strated herein has also been described in several types of
cancer cells [3, 15, 16, 29, 33, 42]. The interaction
between MIR21 and PDCD4 is likely conserved in pigs
as the MIR21 target recognition sequence in the 3′UTR
of human and pig PDCD4 is 97 % similar with 100 %
similarity in nucleotides responsible for recognition by
the MIR21 seed sequence.
Although a multitude of reports demonstrating the
biological activity of miRNA in somatic cells exists
Fig. 2 Luteinizing hormone and follicle stimulating hormone affect oocyte maturation to MII arrest and the lack of FSH numerically decreased
MIR21 expression in MII oocytes. a Maturation rates for oocytes cultured with both LH and FSH (Control), without FSH (− FSH), without LH (−LH)
and without LH and FSH (−LH and FSH). b MIR21 relative expression for GV oocytes and MII oocytes cultured with LH and FSH, without FSH,
without LH and without LH and FSH. a,bMeans ± SEM with different superscripts are different (P < 0.05)
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miRNA function in maturing oocytes has been debated,
primarily the result of the conditional knock-out during
oocyte maturation of enzymes needed for both canonical
and non-canonical miRNA biogenesis pathways. Loss of
DICER function, essential for both siRNA and canonical
miRNA, in developing oocytes results in the production
of non-viable oocytes [38]. Alternatively, using the same
ZP3-cre conditional knock-out approach with a floxed
DGCR8 allele, mice lacking the ability to produce
miRNA through the canonical biogenic pathway still
produced viable oocytes, despite reduced fecundity
[25, 36]. This suggests that while miRNA activity in
mature mice oocytes may be suppressed, miRNA may
still contribute to the developmental competency of
Fig. 3 Cumulus cells influence oocyte maturation but not MIR21abundance in MII arrested oocytes. a Maturation rates for intact COC, denuded
oocytes cultured with cumulus cells, and denuded oocytes. b Expression of MIR21 in GV oocytes, and MII arrested oocytes from intact COC,
denuded oocytes cultured with cumulus cells, and denuded oocytes. a,bMeans ± SEM with different superscripts are different (P < 0.05)








or greater at 60 hf
Average blastomere
# at 60 hg
Control 1646 55.4 ± 3.6a 73.0 ± 5.7a 5.8 ± 1.2 (n = 16)
NC-PNA 1136 49.0 ± 2.5a 60.2 ± 15.8ab 6.3 ± 1.4 (n = 12)
Anti-MIR21 PNA 1639 33.7 ± 3.6b 41.7 ± 12.1b 4.8 ± 1.4 (n = 12)
a,bValues with different superscripts in the same column are significantly different (P < 0.05)
cTreatments include: control maturation conditions, NC-PNA (2.0 nM), anti-MIR21 PNA (2.0 nM)
dTotal number of GV oocytes matured for each treatment from five replications
ePercentage of MII arrested oocytes from each treatment. Mean ± SEM
fPercentage of embryos achieving 4-stage or greater within 60 h following parthenogenetic activation of MII arrested oocytes. Mean ± SEM
gAverage number of blastomeres at 60 h based on a subset of embryos stained with nuclear stain DAPI
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the subsequently produced embryo. This study tested
the hypothesis that increased MIR21 abundance in the
maturing cumulus oocyte complex of the pig is associ-
ated with posttranscriptional regulation of PDCD4
expression in the oocyte and that suppression of
MIR21 function during oocyte maturation would com-
promise subsequent embryonic development.
Utilizing miRNA microarray and small RNA sequencing,
the expression of numerous miRNA in the maturing
porcine cumulus oocyte complex have been previously
demonstrated [41]. The current study further characterizes
the temporal relationship between increased mature MIR21
abundance and decreased PDCD4 protein abundance dur-
ing in vitro maturation of pig oocytes. In cumulus cells,
MIR21 abundance increases approximately 25-fold during
in vitro maturation. This is consistent with reports in
humans [4] and in mice demonstrating increased MIR21
expression in granulosa cells in response to LH [11].
Because MIR21 abundance changes appear to occur rapidly
during in vitro maturation, it is of interest if MIR21 expres-
sion in the pig cumulus oocyte complex is also responsive
to the gonadotropins. To examine this, the ability of both
LH and FSH to affect MIR21 expression during in vitro
maturation was examined. While exclusion of LH from
maturation media negatively impacted oocyte maturation,
as demonstrated by others [45], a significant effect of the
gonadotropins on MIR21 abundance during in vitro matur-
ation was not detected.
Because changes in MIR21 abundance in the oocyte
did not appear to be greatly influenced by LH and FSH
other mechanisms that may contribute to changes in
MIR21 abundance were also investigated. A potential
mechanism explaining the observed increase of MIR21
abundance in IVM derived MII arrested oocytes com-
pared to GV oocytes is that MIR21 could be transported
into the oocyte from the cumulus cells during matur-
ation. This is plausible as other factors have been dem-
onstrated to be translocated between the maturing
oocyte and the surrounding cumulus oophorus [19].
Oocyte - cumulus cell communication is bi-directional
and required for normal cumulus cell gene expression
and oocyte maturation [20] and gap junctions allow the
transit of molecules less than 1000 Da including ATP,
sodium, chloride, calcium ion and cAMP [2, 26]. There-
fore it is feasible that miRNA could also be transported
into the oocyte from surrounding cumulus cells. In
addition to gap junctions, small molecule transport
between cells has also been demonstrated to occur
through exosomes and other microvesicles that can be
secreted and taken up by neighboring cells [39, 40]. The
potential for these mechanisms to contribute to MIR21
abundance increasing in the oocyte was examined by
culturing denuded oocytes during IVM in the presence
or absence of cumulus cells. While a reduction in matur-
ation rate was observed as has been previously demon-
strated [43], MIR21 abundance in the oocytes that did
Fig. 4 PDCD4 protein expression following MIR21 inhibition during IVM. PDCD4 expression abundance is presented relative to PDCD4 expression
in GV oocyte samples (n= 4). From left to right: Control MII arrested oocytes, MII arrested oocytes in vitro matured in the presence of high concentration
(2.0 nM) of the anti-MIR21 PNA or negative control PNA, and MII arrested oocytes in vitro matured in the presence of low concentration (0.2 nM) of the
anit-MIR21 PNA or negative control PNA. Data are presented following normalization to the mean GV stage oocyte band intensity. a,bMeans ± SEM with
different superscripts are different (P< 0.05). Inset is a representative Western blot of PDCD4 protein expression
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achieve MII arrest was not affected by the presence of
cumulus cells suggesting the increased MIR21 observed
is at least in part, the result of oocyte specific
mechanisms.
Taken together neither gonadotropins nor the pres-
ence of cumulus cells during IVM is demonstrably
responsible for increased MIR21 abundance consistently
observed in MII arrested oocytes compared to their GV
stage counterparts. It has also been observed that GVBD
does not occur in the majority of porcine oocytes until
approximately 16–24 h of in vitro maturation [30].
Therefore, it remains possible that the increased abun-
dance of MIR21 in the MII arrested oocyte occurs as a
transcriptional response in the oocyte during the initial
phases of in vitro maturation prior to GVBD in the
oocyte.
These findings taken together suggest the potential for
MIR21 and miRNA in general, to impact protein expres-
sion in the maturing oocyte having implications regarding
the developmental ability of subsequently produced
embryos. Oocyte growth and development begins prior to
antral follicle development and it is unclear when activa-
tion of MIR21 expression occurs or what mechanism is
primarily responsible for this observation. The cumulus
oocyte complexes collected for this study were from 3 to
5 mm antral follicles, prior to GVBD, and may be capable
of transcribing primary MIR21 (pri-MIR21) transcript that
can be further processed into mature MIR21 during mat-
uration. Future studies will include an analysis of pri-
MIR21 abundance prior to and during oocyte maturation
which may yield insight into the mechanisms contributing
to the current observations.
Several promoters have been identified upstream to
the pri-MIR21 transcription start site containing pre-
dicted consensus sequences for binding of AP-1 and sig-
nal transducer and activator of transcription 3 (STAT3)
[17]. In certain cancers, the interaction between MIR21
and PDCD4 is necessary for maximal AP-1 activation.
AP-1 activation is suppressed by PDCD4, however, AP-1
induction of MIR21 and subsequent posttranscriptional
regulation of PDCD4 allows further and more sustained
AP-1 activation [17, 37]. In addition to AP-1, STAT3 is
another transcription factor that has also been docu-
mented to induce pri-MIR21 transcription [23]. It is pos-
sible that STAT3 could be related to the expression of
MIR21 during oocyte maturation and early embryo
development as leptin (an adipokine) has been
Fig. 5 In situ hybridization of MIR21 in gilt ovaries to identify MIR21
expression during follicle development. Scale bars represent 50
micron in all images. Images are representative of eight biological
replications. MIR21 expression was designated green and nuclei
(DAPI staining) designated blue. Laser intensity and exposure time
was consistent for all images captured
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demonstrated to increase STAT3 expression during
bovine embryo culture and is associated with reduced
apoptosis in bovine blastocysts [7]. In addition, leptin has
been shown to increase STAT3 expression in both cumu-
lus cells and oocytes during in vitro maturation and
enhance the oocytes ability to complete meiosis [32].
Conclusion
In summary, these data demonstrate MIR21 miRNA and
PDCD4 protein have a reciprocally inverse, temporal
expression pattern during oocyte maturation, and that
inhibition of MIR21 results in an increased abundance
of PDCD4 protein. MIR21 expression in MII arrested
oocytes matured in vitro was not affected by gonadotro-
pins or the presence of cumulus cells during in vitro
maturation. It is possible that increased MIR21 expres-
sion in the oocyte occurs earlier during oocyte recruit-
ment or during initial in vitro maturation prior to
GVBD and warrants further investigation. Obtaining an
understanding of MIR21 and its mechanism is necessary
to further understand molecular regulation of oocyte
maturation and early embryo development in the pig.
Understanding molecular mechanisms of early embryo
development will provide a more comprehensive under-
standing of mammalian reproduction that can be funda-
mental in developing strategies to improve reproductive
efficiency.
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